Citations

Clear

17 citation(s) found for "Nelson, David".

Racial and Ethnic Variation in Perceptions of VA Mental Health Providers are Associated With Treatment Retention Among Veterans With PTSD
Spoont, Michele , Nelson, David , Ryn, Michelle van , Alegrı́a, Margarita , van Ryn, Michelle

Mayo Clinic

Medical Care | August 11, 2017 | Volume: 55 | Issue: Suppl 2 | Pages: S33-S42

10.1097/mlr.0000000000000755 | PMID 28806364 Get It

Background: Veterans with posttraumatic stress disorder (PTSD) who seek mental health care in the Veterans Health Administration frequently discontinue treatment prematurely. Early discontinuation of mental health treatment is more common among Veterans with PTSD who are of minority race or ethnicity. Objectives: To determine whether retention in individual therapy or pharmacotherapy among Veterans with PTSD are associated with patients’ ratings of their mental health providers, and if those associations differ depending on Veteran race or ethnicity. Research Design: Latino, African American, and white Veterans (n=2452) who participated in a prospective national cohort study of Veterans with PTSD at the beginning of an episode of care were surveyed immediately following Veterans’ PTSD diagnoses and 6 months later. Pharmacy and mental health service utilization were abstracted from Veterans Health Administration administrative databases for 6 months postdiagnosis. Retention in treatments were modeled using logistic regression among Veterans who initiated individual therapy or pharmacotherapy. Demographics, treatment need, treatment-related beliefs, treatment process measures, and ratings of mental health providers were considered as predictors. Results: Ratings of mental health providers, more than treatment beliefs, were associated with treatment retention. Among African American Veterans, retention in pharmacotherapy was reduced if the provider was perceived as not having helped manage medication side-effects (odds ratio, 0.36; confidence interval, 0.16–0.80). All Latino Veterans but one (99% or n=64) who rated their therapist as not caring discontinued individual psychotherapy. Conclusions: Ratings of mental health providers were associated with treatment retention. The salience of specific provider behaviors to treatment retention varied by Veteran race or ethnicity.
Phase Ib study of mapatumumab in combination with sorafenib in patients with advanced hepatocellular carcinoma (HCC) and chronic viral hepatitis.
Sun, Weijing , Nelson, David , Poordad, F., Leong, Stephen , Teitelbaum, Ursina , Fox, N. L., O’Neil, Bert H. , Alberts, Steven R. , Woods, Laura M.

Mayo Clinic

Journal of Clinical Oncology | February 23, 2017 | Volume: 29 | Issue: 4_suppl | Pages: 261-261

10.1200/jco.2011.29.4_suppl.261 Get It

261 Background: Mapatumumab is a fully human agonist monoclonal antibody to the tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1). Sorafenib targets Mcl-1, a key TRAIL resistance protein, and accordingly could enhance mapatumumab's pro-apoptotic activity. Based on this and on preclinical data on mapatumumab in HCC cell lines, the current dose-escalation study is evaluating mapatumumab in combination with sorafenib in patients with advanced HCC. Methods: Eligible patients had advanced HCC, Child-Pugh A or Model for End-Stage Liver Disease score < 15, and were positive for hepatitis B surface antigen or hepatitis C antibody. Intravenous mapatumumab was administered at 3, 10 or 30 mg/kg every 21 days with sorafenib (400 mg twice daily) until disease progression or unacceptable toxicity. Dose-limiting toxicities (DLTs) included events considered at least possibly related to mapatumumab and/or its interaction with sorafenib. Tumor measurements were performed every 2 cycles. Dose escalation required at least 3 patients in a cohort to receive >= 50% of full-dose sorafenib in the first 2 cycles. Results: To date, 19 patients have been enrolled in the 3 mg/kg (n=6), 10 mg/kg (n=9) and 30 mg/kg (n=4) cohorts and have received a median of 4 cycles (range 1 to 24 cycles); 4 patients have received >= 11 cycles. The maximum tolerated dose has not been reached. DLTs that prompted expansion of the 3 mg/kg and 10 mg/kg cohorts were elevations of amylase and/or lipase (1 at 3 mg/kg, 1 at 10 mg/kg). Other Grade 3-4 events considered at least possibly related to mapatumumab and/or its interaction with sorafenib included hepatic pain (1/17), thrombocytopenia (1/17), increased aspartate aminotransferase (1/17), increased lipase (1/17), and increased gamma-glutamyltransferase (1/17). Two patients have had a partial response and 4 patients have had stable disease lasting > 12 weeks, based on investigator assessment. Conclusions: Mapatumumab was well-tolerated at doses up to 30 mg/kg in combination with sorafenib in patients with HCC and viral hepatitis. A randomized phase II study of this combination in patients with advanced HCC is planned. [Table: see text]
The mixed impact of medical school on medical students’ implicit and explicit weight bias
Puhl, Rebecca M. , Burke, Sara E. , Nelson, David , Przedworski, Julia , Perry, Sylvia , Yeazel, Mark W. , Ryn, Michelle van , Phelan, Sean M. , van Ryn, Michelle, Hardeman, Rachel R. , Dovidio, John F. , Burgess, Diana Jill , Perry, Sylvia P , van Ryn, Michelle

Mayo Clinic

Medical Education | September 18, 2015 | Volume: 49 | Issue: 10 | Pages: 983-992

10.1111/medu.12770 | PMID 26383070 Get It

Context Health care trainees demonstrate implicit (automatic, unconscious) and explicit (conscious) bias against people from stigmatised and marginalised social groups, which can negatively influence communication and decision making. Medical schools are well positioned to intervene and reduce bias in new physicians. Objectives This study was designed to assess medical school factors that influence change in implicit and explicit bias against individuals from one stigmatised group: people with obesity. Methods This was a prospective cohort study of medical students enrolled at 49 US medical schools randomly selected from all US medical schools within the strata of public and private schools and region. Participants were 1795 medical students surveyed at the beginning of their first year and end of their fourth year. Web‐based surveys included measures of weight bias, and medical school experiences and climate. Bias change was compared with changes in bias in the general public over the same period. Linear mixed models were used to assess the impact of curriculum, contact with people with obesity, and faculty role modelling on weight bias change. Results Increased implicit and explicit biases were associated with less positive contact with patients with obesity and more exposure to faculty role modelling of discriminatory behaviour or negative comments about patients with obesity. Increased implicit bias was associated with training in how to deal with difficult patients. On average, implicit weight bias decreased and explicit bias increased during medical school, over a period of time in which implicit weight bias in the general public increased and explicit bias remained stable. Conclusions Medical schools may reduce students’ weight biases by increasing positive contact between students and patients with obesity, eliminating unprofessional role modelling by faculty members and residents, and altering curricula focused on treating difficult patients.
Implicit and explicit weight bias in a national sample of 4,732 medical students: The medical student CHANGES study
Dovidio, John F. , Puhl, Rebecca M. , Nelson, David , Yeazel, Mark W. , Perry, Sylvia , Ryn, Michelle van , Phelan, Sean M. , Burgess, Diana Jill , Hardeman, Rachel R. , Perry, Sylvia P , van Ryn, Michelle

Mayo Clinic

Obesity | December 23, 2013 | Volume: 22 | Issue: 4 | Pages: 1201-1208

10.1002/oby.20687 | PMID 24375989 Get It

ObjectiveTo examine the magnitude of explicit and implicit weight biases compared to biases against other groups; and identify student factors predicting bias in a large national sample of medical students.MethodsA web‐based survey was completed by 4,732 1st year medical students from 49 medical schools as part of a longitudinal study of medical education. The survey included a validated measure of implicit weight bias, the implicit association test, and 2 measures of explicit bias: a feeling thermometer and the anti‐fat attitudes test.ResultsA majority of students exhibited implicit (74%) and explicit (67%) weight bias. Implicit weight bias scores were comparable to reported bias against racial minorities. Explicit attitudes were more negative toward obese people than toward racial minorities, gays, lesbians, and poor people. In multivariate regression models, implicit and explicit weight bias was predicted by lower BMI, male sex, and non‐Black race. Either implicit or explicit bias was also predicted by age, SES, country of birth, and specialty choice.ConclusionsImplicit and explicit weight bias is common among 1st year medical students, and varies across student factors. Future research should assess implications of biases and test interventions to reduce their impact.
Faculty Perceptions of How Community‐Engaged Research Is Valued in Tenure, Promotion, and Retention Decisions
Nokes, Kathleen M. , Nelson, David , McDonald, Mary Anne , Hacker, Karen , Gosse, Jacquelyn, Sanford, Becky, Opel, Shannon, Sanford, Becky

Mayo Clinic

Clinical and Translational Science | August 6, 2013 | Volume: 6 | Issue: 4 | Pages: 259-266

10.1111/cts.12077 | PMID 23919360 Get It

AbstractPurposeWe assessed the perceptions of community core faculty in academic medical center institutions that received Clinical and Translational Science Awards (CTSA) about how these institutions consider community‐engaged scholarship (CES) when tenure, promotion, and retention decisions are made.MethodAn assessment tool was adapted to create an 18‐item survey that was sent during November and December 2011 via the Internet to the 369 members of the community‐engagement core mailing list of the CTSA.ResultsFifty‐nine responses were received which represented 37 of the possible 60 different funded institutions. The mean score was 48.14 (SD = 11.18); range of 23–74; and Cronbach's alpha was .91 About half reported that support for CES and its inclusion in the academic decision process increased since the institution was awarded a CTSA. Open‐ended responses indicated some confusion with terminology although a definition of CES had been provided in the instrument instructions.ConclusionRespondents overall agreed there was moderate support for CES in tenure, promotion, and retention decisions which may have been influenced by the CTSA application requirements. This survey could be used to identify if there are differences in institutional and departments and measure changes over time.
Endocrinopathies in the Cardiac ICU
Schwartz, Steven M. , Portman, Michael A. , Crow, Sheri, Nelson, David P. , Anand, Kanwaljeet J. S. , Zimmerman, Jerry J.

Mayo Clinic

World Journal for Pediatric and Congenital Heart Surgery | July 25, 2011 | Volume: 2 | Issue: 3 | Pages: 400-410

10.1177/2150135111406941 | PMID 23803992 Get It

The past several years have seen an increased appreciation of the potential role of the endocrine system in the recovery process following surgery for congenital heart disease. Many of the hormonal changes following cardiac surgery are adaptive and necessary, whereas activation of proinflammatory cytokine and chemokine responses and some of the metabolic changes following surgery are likely mediators leading to detrimental outcomes. Additionally, other hormonal perturbations may contribute to adverse outcomes. This review examines the pain and the stress response, thyroid function and hyperglycemia following cardiopulmonary bypass (CPB), and the potential role of corticosteroids in the pediatric cardiac critical care unit.
The Selaginella Genome Identifies Genetic Changes Associated with the Evolution of Vascular Plants
Banks, Jo Ann , Nishiyama, Tomoaki , Hasebe, Mitsuyasu , Bowman, John L. , Gribskov, Michael , dePamphilis, Claude W. , Albert, Victor A. , Aono, Naoki, Aoyama, Tsuyoshi , Ambrose, Barbara A. , Ashton, Neil W., Axtell, Michael J. , Barker, Elizabeth I. , Bonawitz, Nicholas D. , Chapple, Clint , Cheng, Chaoyang , Corrêa, Luiz Gustavo Guedes, Dacre, Michael , DeBarry, Jeremy D. , Drèyer, Ingo , Engstrom, Eric M., Estelle, Mark , Feng, Liang , Finet, Cédric , Floyd, Sandra K., Gramzow, Lydia , Harholt, Jesper , Hattori, Mitsuru , Heyl, Alexander , Hirai, Tadayoshi , Hiwatashi, Yuji , Ishikawa, Masaki , Iwata, Mineko, Karol, Kenneth G. , Koehler, Barbara, Kolukisaoglu, Uener, Kubo, Minoru , Kurata, Tetsuya , Lalonde, Sylvie, Li, Kejie , Litt, Amy , Manning, Gerard , Michael, Todd P. , Miyazaki, Saori , Morinaga, Shin‐Ichi, Murata, Takashi, Nelson, David R. , Obara, Mari, Oguri, Yasuko, Olmstead, Richard G. , Onodera, Naoko T., Petersen, Bent Larsen , Pils, Birgit, Prigge, Michael J. , Riaño‐Pachón, Diego Mauricio , Scheller, Henrik Vibe , Schulz, Burkhard , Schulz, Christian , Shakirov, Eugene V. , Shibagaki, Nakako, Shippen, Dorothy E. , Sørensen, Iben , Sotooka, Ryo, Sugimoto, Nagisa , Sugita, Mamoru , Sumikawa, Naomi, Tanurdžić, Miloš , Theißen, Günter, Ulvskov, Peter , Wakazuki, Sachiko, Weng, Jing‐Ke , Willats, William G. T. , Wipf, Daniel , Wolf, Paul G. , Yang, Lixing , Zimmer, Andreas , Zhu, Qihui , Mitros, Therese , Hellsten, Uffe, Loqué, Dominique , Otillar, Robert, Salamov, Asaf, Shapiro, Harris , Lindquist, Erika , Lucas, Susan , Rokhsar, Daniel S. , Grigoriev, Igor V. , Ashton, Neil W., Barker, Michael S. , Bennetzen, Jeffrey L. , Eliáš, Marek , Frommer, Wolf Bernd , Fujita, Tomomichi , Gutensohn, Michael , Li, Ying , Lyons, Eric H. , Maruyama, Takeshi , Mikami, Koji , Murata, Takashi , Mueller‐Roeber, Bernd , Oguri, Yasuko, Rensing, Stefan Andreas , Roberts, Alison W. , Sato, Yoshikatsu , Shinohara, Naoki , Schmutz, Jeremy

Mayo Clinic

Science | May 5, 2011 | Volume: 332 | Issue: 6032 | Pages: 960-963

10.1126/science.1203810 | PMID 21551031 Get It

The genome sequence of a lycophyte hints at ancient evolutionary transitions.